Cancer Screening Trust

Cancer Screening Trust A non-profit organisation dedicated to providing the latest in cancer screening for early detection in over 70 types of cancer.

“It starts with a conversation in a pub.”When we first heard about the initiative behind Durham and District Prostate Ca...
21/04/2026

“It starts with a conversation in a pub.”

When we first heard about the initiative behind Durham and District Prostate Cancer Group, it was exactly that - a community-led idea driven by people who had experienced prostate cancer firsthand and wanted to make a difference. Their mission was simple but urgent: to raise awareness of what is often called the silent killer.

But as the organiser, Tom Sharples, shared with us, “the project was proving far more complicated than expected. The logistics, the medical requirements, the coordination, it was overwhelming.”

That’s where CST stepped in.

“In just three weeks, Les’s vision, which had seemed too difficult, too complex, became a reality.” CST were able to coordinate and deliver the screening events and help Les and Tom to turn “determination into action”.

“Sixty-four men came forward for testing.
Each man received their results within a week.
Sixty-four men who might otherwise have remained unaware.
Sixty-two tests were normal.
Two were abnormal.
Early detection that could make all the difference.”

This is why accessible, community-led screening matters.

We’re incredibly proud to support initiatives like this — and to work alongside people whose determination turns conversations into life-saving action.

If you’re looking to organise a screening event in your community, we’d be happy to help make it happen.

Read Tom Sharples’ full story on our blog: https://lnkd.in/eiWznUmj

Group photograph from the left - Peter Carr (D&DPCG), Colin Dye (BCAD), Ray Brown (D&DPCG), Bob Clough (D&DPCG), Les Cleckner (D&DPCG Lead), Tom Sharples (Chair BCAD), Geoff Kitson (Durham City Freemen), Cllr Gary Hutchinson (Mayor of Durham), Eric Bulmer (Chair Durham City Freemen Charitable Trust), Debra Adams (D&DPCG), John Turnbull (Parish Councillor), Pam Cleckner (D&DPCG)

(D&DPCG) - Durham and District Prostate Cancer Group
(BCAD) - Brandon Community Association Durham

Trucheck FemmeSafe is now available at The Cancer Screening Trust. It is a blood-based screening test based on the prese...
01/05/2024

Trucheck FemmeSafe is now available at The Cancer Screening Trust. It is a blood-based screening test based on the presence of Circulating Tumour Cells and validated to detect: breast, ovarian, uterine and cervical cancer.

Cancers of the breast, o***y, uterus and cervix account for approximately 3.6 million diagnosed cases and 1.3 million deaths in women worldwide, each year (Globocan, 2020). Early detection of these cancers results in more effective treatments and increased survival prospects.

Find out more and enquire today on our website: www.thecancerscreeningtrust.co.uk/screening-tests

April is Bowel Cancer Awareness month in the UK. Bowel cancer is the fourth most common cancer in the UK and the second ...
19/04/2024

April is Bowel Cancer Awareness month in the UK. Bowel cancer is the fourth most common cancer in the UK and the second biggest cancer killer. Nearly 43,000 individuals are diagnosed with bowel cancer every year in the UK (Bowel Cancer UK, July 2023). The FIT test is used as a bowel cancer screening method and is now available at CST for all individuals over 18 years old.

Find out more on our website and enquire today: www.thecancerscreeningtrust.co.uk

The Cancer Screening Trust are offering a Comprehensive Hereditary Cancer Panel that includes 31 genes associated with t...
01/03/2024

The Cancer Screening Trust are offering a Comprehensive Hereditary Cancer Panel that includes 31 genes associated with the most common hereditary cancers. It is used to identify individuals at a higher-than population risk for hereditary cancer from a simple saliva sample.

Find out more on our website: www.thecancerscreeningtrust.co.uk/screening-tests

In recent light of World Cancer Day, The Cancer Screening Trust are here to support people and communities to raise awar...
09/02/2024

In recent light of World Cancer Day, The Cancer Screening Trust are here to support people and communities to raise awareness and take action against cancer. Detecting cancer as early as possible allows individuals to have the best chance for successful treatment. Screening can help prevent the development of cancers and detect it at an early stage. It is estimated that over 5000 lives are saved by the cancer screening programmes each year in the UK (www.news.cancerresearchuk.org/2024/02/02/world-cancer-day-2024). The Cancer Screening Trust aim to increase this, with the Trucheck Intelli blood test that is validated to detect over 70 different types of cancer at the earliest of stages. Find out more on our website: www.thecancerscreeningtrust.co.uk

Datar Cancer Genetics, who developed Trucheck Intelli, have conducted research studies on a 'world-first' blood test whi...
29/01/2024

Datar Cancer Genetics, who developed Trucheck Intelli, have conducted research studies on a 'world-first' blood test which can diagnose glial tumours including: glioblastoma (GBM), the most commonly-diagnosed high-grade brain tumour in adults, astrocytomas and oligodendrogliomas. They found the test had 'high analytical sensitivity, specificity and precision'. Such a non-invasive and inexpensive method for early detection of brain tumours is critical for improvements in patient care.

Whilst there is still some way to go, it uses similar methods to that of Trublood by detecting intact circulating tumour cells from the blood, which can be analysed to the same cellular detail as an actual tissue sample.

CST are currently offering Trublood products as well as a number of others, find out more on our website: www.thecancerscreeningtrust.co.uk

One person a minute in Britain will be diagnosed with cancer by 2040 according to a recent article from The Times (www.t...
05/01/2024

One person a minute in Britain will be diagnosed with cancer by 2040 according to a recent article from The Times (www.thetimes.co.uk/article/cancer-diagnosis-warning-2040-research-uk-sb8bdrg2z). Investment in research to prevent this is failing to keep up with the ever-increasing burden of cancer according to Michelle Mitchel, chief executive of Cancer Research UK. In the UK, there are an estimated 419,935 cases of cancer annually and if the present trend persists, this will rise to 505,565 by 2040 along with deaths from 176,376 to 208,022.

With a focus on healing yourself, middle-aged adults can help prevent thousands of cases by removing unhealthy habits from their lifestyle such as smoking, excessive drinking, and obesity.

However, there are reasons to be optimistic, one being the use of blood tests as an early diagnostic screening method. In the UK, a worse prognosis is generally thought to be caused by late diagnosis where cancers are typically harder to treat. Blood tests such as Trucheck Intelli can be used as a screening tool to detect cancers at the earliest stages using Circulating Tumour Cells with 88.2% sensitivity. Early detection means that treatment is more likely to be successful. Find out more on our website today: www.thecancerscreeningtrust.co.uk

Happy New Year to everyone from CST! We have achieved lots during a busy year thanks to our hard working staff, clinical...
02/01/2024

Happy New Year to everyone from CST! We have achieved lots during a busy year thanks to our hard working staff, clinical team and loyal clients. In 2023, we started providing genetic tests for cancer, successfully made it through to the next stage of the Somerset Business Awards, ran a marathon for cancer awareness and had a Telegraph article written for CST and the Trucheck Intelli blood test. We aim to continue to support the early detection of cancer and change lives in 2024.

We are delighted to announce that The Cancer Screening Trust has successfully made it through to the next round of the S...
13/12/2023

We are delighted to announce that The Cancer Screening Trust has successfully made it through to the next round of the Somerset Business Awards in the Start-Up of the Year category. We are glad that this recognition will help us with our mission to spread awareness about early cancer detection.

Address

Zeal House, 8 Deer Park Road, Merton
London
SW193UU

Opening Hours

Monday 9am - 5:30pm
Tuesday 9am - 5:30pm
Wednesday 9am - 5:30pm
Thursday 9am - 5:30pm
Friday 9am - 5:30pm

Alerts

Be the first to know and let us send you an email when Cancer Screening Trust posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Cancer Screening Trust:

Share